By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Viking Therapeutics, Inc. (Form S-1) was posted on July 1, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 52 documents filed with this form. The SEC file number is 0001193125-14-257855.
The contact information for this company is 11119 NORTH TORREY PINES ROAD, SUITE 50, SAN DIEGO CA 92037, 858-550-7810.
Our editors provided additional information about Form S-1: This is the basic registration form. It can be used to register securities for which no other form is authorized or prescribed, except securities of foreign governments or political sub-divisions thereof.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1607678/0001193125-14-257855-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Viking Therapeutics Inc.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
